



You are here: Home > Pharmacy News | Health Articles/Tips > Indian Drugs Approved by USFDA > January 09, 2009
India's Sun Pharma gets FDA nod for four genericsPosted AtTopnews.inIndia-based Sun Pharmaceutical Industries Ltd has made announcement that the company along with its arm, has got first U.S. Food and Drug Administration sanction to market the generic version of a controlled substance in tablet form. According to sources, the company is allowed to sell generic hydrocodone bitartate with acetaminophen in multiple strengths, which has a U.S. market size of $540 million for branded and generic versions. Sun also secured approval for generic versions of cholesterol-fighting Lopid, Aredia, indicated in the treatment of high blood calcium, and anti-allergent Phenargen in multiple strengths. January 09, 2009
|